Our data strongly support the concept that in AD microRNA-146a upregulation contributes to tau hyperphosphorylation and cytoskeleton disruption by impeding the ROCK1-PTEN signaling pathway. The gene discussed is ROCK1; the disease is Alzheimer disease.